Drug Pipeline

68Ga-PSMA-11 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
3
Recruiting
2
Phase 3
5
Top Sponsors
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT04886986
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic…		 overall status: "Active Not Recruiting" → "Recruiting"
2026-06-12 NCT04886986
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic…		 Enrollment increased: 20 -> 42 participants
2026-06-09 NCT05670106
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of…		 Trial completed
2026-06-09 NCT05670106
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of…		 date change Completion moved earlier: 2026-06-30 -> 2026-04-22
2026-05-28 NCT05849298
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With…		 Trial sites reduced: 41 -> 37 locations
Active Studies by Phase
Phase 3
2
Phase 2
4
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04689828 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive… Prostatic Neoplasms Active, Not Recruiting
NCT04720157 An International Prospective Open-label, Randomized, Phase III Study Comparing… Prostatic Neoplasms Active, Not Recruiting
Phase 2
NCT06444412 An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or… WHO Grade 3 Glioma Recruiting
NCT06004661 Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and… Metastatic Castration-Resistant Prostate Cancer (mCRPC) Recruiting
NCT04777071 An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer Biochemically Recurrent Prostate Carcinoma Active, Not Recruiting
NCT05849298 A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With… Prostatic Neoplasm Active, Not Recruiting
Phase 1/2
NCT07117760 Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic… Prostate Cancer Active, Not Recruiting
Phase 1
NCT04886986 Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic… Prostate Cancer Recruiting
Sponsors Running 68Ga-PSMA-11 Trials
Novartis Pharmaceuticals (4) University of Washington (1) Weill Medical College of Cornell University (1) Mayo Clinic (1) First Affiliated Hospital of Fujian Medical University (1)
Disease Areas
Prostate Cancer (4) Glioma (1)
Get alerts when 68Ga-PSMA-11 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free